A bill for an act relating to manufacturers and distributors of 340B drugs.

This Iowa bill (HF 590) prohibits drug manufacturers and distributors from interfering with safety-net hospitals, clinics, and other covered entities acquiring or receiving 340B discounted drugs. It specifically bans manufacturers or distributors from denying, restricting, or hindering these transactions - except when federal health officials prohibit them. The law defines key terms like "340B drug," "distributor," and "manufacturer" based on federal Social Security Act standards. It directly affects drug companies and wholesalers operating in Iowa by requiring compliance with federal 340B program rules. The bill was introduced in February 2025 and remains pending.